We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
The potential of native microalgae consortia to remove pharmaceutical compounds present in treated wastewater
AI summary Read the abstract
Researchers assessed the ability of native microalgae consortia to remove pharmaceutical compounds from treated wastewater over a one-year study period. They detected and quantified 19 pharmaceutical compounds across multiple drug classes and found that the microalgae achieved varying removal efficiencies depending on the compound. The study suggests that microalgae-based treatment could complement conventional wastewater processing to reduce pharmaceutical contamination reaching aquatic environments.
Wastewater treatment plants play a key role in the release of pharmaceuticals and other contaminants into the aquatic environment, causing negative effects on the ecosystems of receiving water bodies. This work aimed to assess the removal efficiency of real loads of these contaminants by wastewater-native microalgae consortia acting on treated wastewater previously subjected to secondary treatment. Wastewater sampling and removal efficiency experiments were conducted over 1 year at three different sampling points. Nineteen pharmaceutical compounds of different drug classes (stimulants, anticonvulsants, antidepressants, antibiotics, β-blockers, lipid regulators, and nonsteroidal anti-inflammatory drugs/analgesics), as well as one herbicide/algicide (Diuron) were detected and quantified. Native blooming microalgae consortia were grown in treated wastewaters, and their potential to remove these compounds was quantified. The removal efficiency of these compounds by native microalgae consortia was variable, ranging from almost no removal for Clofibric acid or Ketoprofen to near complete removal for Fluoxetine, Venlafaxine, Atenolol or Diuron. These variations were influenced not only by the molecular nature of the compounds but also by the microbial composition variability of the microalgae consortia, especially among the prokaryotes present. Overall, microalgae consortia successfully removed between 40 % and 83 % of the total detected compounds, preventing a significant part of these from entering the aquatic environment, contributing to enhance treated wastewater quality. Significant biomass growth was observed, reaching dry-weight concentrations up to 2.6 g.L-1, indicative of good capacity of the grown consortia to deal with the toxicity effects of the pollutants. In addition to what is now reported, microalgae treatment also removes other pollutants, such as nutrients, metals or microplastic particles, constituting a versatile tertiary treatment for polishing treated wastewaters. These findings demonstrate the potential of native microalgae consortia-based systems to improve wastewater treatment processes, mitigating the environmental impact of pharmaceutical compounds while producing potentially useful biomass.
More Papers Like This
Are native microalgae consortia able to remove microplastics from wastewater effluents?
AI summary Read the abstract
Researchers investigated whether native microalgae communities found in wastewater could effectively remove microplastics from treatment plant effluent. The study monitored microplastic occurrence across two different types of wastewater treatment plants over one year, characterizing particles by shape, size, and polymer type. Evidence indicates that wastewater-native microalgae consortia show potential as a dual-purpose solution for both microplastic mitigation and biomass production.
The occurence of pharmaceuticals and other micropollutants in wastewater treatment plant in the aspect of interaction with microplastics
AI summary Read the abstract
Researchers analysed the occurrence of antibiotics, virucidal, and fungicidal pharmaceuticals in raw and treated sewage at a wastewater treatment plant in southern Poland, examining their removal efficiency and potential interactions with microplastics present in the effluent. The study found that pharmaceutical micropollutants persisted through treatment to varying degrees, raising concerns about combined contamination pathways when microplastics act as co-vectors for these compounds.
Determination of the pharmaceuticals–nano/microplastics in aquatic systems by analytical and instrumental methods
AI summary Read the abstract
Researchers reviewed analytical and instrumental methods for detecting pharmaceutical compounds associated with nano- and microplastic particles in aquatic systems. They examined how pharmaceuticals bind to plastic particles and the combined environmental risks these mixtures pose to water sources and marine life. The study identifies gaps in current detection capabilities and calls for improved methods to assess the combined impact of these co-occurring pollutants.
Bioremediation Using Microalgae and Circular Economy Approach: A Case Study
AI summary Read the abstract
Researchers investigated the use of microalgae for bioremediation of water pollutants including nano- and microplastics, pharmaceuticals, and heavy metals, presenting a circular economy case study demonstrating how microalgal biomass can simultaneously treat contaminated water and generate value-added products.
Influence of polystyrene microplastics on levofloxacin removal by microalgae from freshwater aquaculture wastewater
AI summary Read the abstract
Researchers found that polystyrene microplastics inhibited Chlorella vulgaris growth and reduced its efficiency in removing the antibiotic levofloxacin from freshwater aquaculture wastewater, demonstrating that microplastic pollution can impair microalgae-based water treatment systems.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.